Category 2 Placement: The FDA placed BPC-157 in Category 2 of the 503A bulk drug substances list, citing "significant safety concerns." This effectively blocked compounding pharmacies from preparing BPC-157 formulations for patients
Our findings also indicate that there is no obvious difference between treatment discontinuation and low adherence in this type of data: whether patients who have long gaps between filled prescriptions should be considered as having discontinued and reinitiated treatment or as having poor adherence is not clear
Rao, A., Barkley, D., Frana, G
Our GLP-1 probiotic contains natural ingredients like Licorice, Ginger Root, Bromelain, Aloe Vera Extract, and Magnesium good for in digestive system
Church FC (2021) Treatment options for motor and non-motor symptoms of parkinsons disease
The above section explains glutathione benefits